Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV

Ann C. Collier, Camlin Tierney, Gerald F. Downey, Susan H. Eshleman, Angela Kashuba, Karin Klingman, Emanuel N. Vergis, Gary E. Pakes, James F. Rooney, Alex Rinehart, John W. Mellors, George Bishopric, Barbara Brizz, Marlene Cooper, Linda Gideon, Nicole Grosskopf, Belinda Ha, Bernadette Jarocki, Ana Martinez, Jane ReidTrevor Scott, Nancy Tustin, Ed Acosta, Merissa L. Astley, Benigno Rodriguez, Patricia Walton, Judith Feinberg, Jenifer Baer, Luis M. Mendez, Frances Canchola, Michael F. Para, Laura Laughlin, Joseph J. Eron, Cheryl Marcus, Valery Hughes, Todd Stroberg, Brad Hare, Jody Lawrence, Daniel J. Skiest, Jesse Tarbutton, William A. O'Brien, Cheryl Mogridge, Karen Cavanagh, Charles Gonzalez, Hector H. Bolivar, Margaret A. Fischl, N. Jeanne Conley, Laura Olin, Mitchell Goldman, Beth Zwickl, Donna Mildvan, Donald Garmon

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV'. Together they form a unique fingerprint.

Medicine & Life Sciences